Elevance Health Inc.

(New York Stock Exchange)
Back to all articles
Somewhat Bullish +50

Cardinal Health (CAH) Reports Q1: Everything You Need To Know Ahead Of Earnings

AI-generated analysis

πŸ“… Cardinal Health (CAH) is scheduled to report its Q1 earnings results this Thursday before market hours.

πŸ’° Last quarter, Cardinal Health beat analysts' revenue expectations with total revenues of $65.63 billion.

πŸ“ˆ Year-over-year revenue growth was 18.8%, marking a strong performance for the company.

🎯 The company also surpassed analysts' full-year EPS guidance estimates and current EPS estimates.

πŸ“‰ Analysts currently expect revenue to grow by 13.5% year-on-year in the upcoming quarter.

⬆️ Revenue estimates have seen upward revisions over the last 30 days as sentiment grows bullish.

⚠️ Cardinal Health has missed Wall Street's revenue estimates multiple times over the past two years.

πŸ₯ Peer comparison shows Elevance Health and UnitedHealth both reported positive Q1 results with revenue beats.

πŸ“Š Peers in the healthcare segment saw share prices rise, with an average increase of 10.8% over the last month.

πŸ“‰ Cardinal Health's stock price remained unchanged during the same period as its peers.

πŸ’΅ Analysts maintain an average price target of $248.27 compared to a current share price of $206.15.

Bullish Signals
  • Cardinal Health beat analysts' revenue expectations last quarter with revenues of $65.63 billion, representing an 18.8% year-over-year increase.
  • The company also surpassed analysts' full-year EPS guidance estimates and current quarter EPS estimates, indicating strong performance.
  • Analysts covering the stock have grown increasingly bullish, evidenced by a majority of upward revisions to revenue estimates over the last 30 days.
  • Market expectations for Cardinal Health's revenue growth in the upcoming quarter are set at 13.5% year-over-year, reflecting improving sentiment after a flat previous period.
  • Positive sentiment is evident in the broader healthcare providers & services segment, with peer stocks like UnitedHealth and Elevance Health seeing share price gains of 9.3% and 5.5% respectively following their results.
  • Cardinal Health's stock has an average analyst price target of $248.27 compared to the current share price of $206.15, suggesting significant upside potential.
Risk Factors
  • Cardinal Health has missed Wall Street's revenue estimates multiple times over the last two years, creating a pattern of earnings disappointments.
  • Despite current analyst bullishness and upward revisions to revenue estimates, the stock price remains significantly undervalued at $206.15 compared to the average analyst target of $248.27.
  • The company's Q1 revenue growth expectation of 13.5% is a stark contrast to its flat performance in the same quarter last year, indicating potential volatility or difficulty in sustaining high growth rates.
  • While peer competitors Elevance Health and UnitedHealth delivered strong results with significant stock gains, Cardinal Health's shares were unchanged over the same period, suggesting underperformance relative to industry benchmarks.
Full Analysis
Cardinal Health (NYSE: CAH) is preparing to report its first-quarter earnings on Thursday before market hours, with the company having already surpassed analysts' revenue expectations in the previous quarter. Last quarter, Cardinal Health reported revenues of $65.63 billion, representing an 18.8% year-over-year increase. The company also beat analysts' full-year EPS guidance and current EPS estimates during that prior period. For the current quarter ahead of earnings, market expectations are for revenue growth of 13.5% year over year, which would mark an improvement from the flat revenue reported in the same quarter last year. Analysts covering Cardinal Health have recently become more bullish, with a majority of revenue estimates seeing upward revisions over the last 30 days. Despite this recent positive sentiment and multiple beats against analyst estimates over the past two years, the company has missed Wall Street's revenue estimates multiple times in that same timeframe. This stands in contrast to some of its peers in the healthcare providers & services segment that have already reported their Q1 results; Elevance Health delivered 1.5% year-over-year revenue growth while beating expectations by 2.4%, and UnitedHealth reported revenues up 2%, topping estimates by 1.7%. Both Elevance Health and UnitedHealth saw their share prices increase following their respective reports, with the broader healthcare providers & services segment showing an average share price gain of 10.8% over the last month. Current investor sentiment is reflected in Cardinal Health's stock price, which remains unchanged compared to a recent period, though it trades below its average analyst price target. The average analyst price target for Cardinal Health is set at $248.27, compared to the current share price of $206.15. These figures are based on data reported in an article dated Wednesday, April 29, 2026.